{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Ridgewood",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "87711",
      "recalling_firm": "Hyobin LLC",
      "address_1": "455 S Pleasant Ave",
      "address_2": "N/A",
      "postal_code": "07450-5413",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "USA Nationwide",
      "recall_number": "D-0382-2021",
      "product_description": "PremierZen Black 5000, packaged in   cardboard blisters containing one capsule per card, Distributed by Yolo Studio,  Cliffside Park, NJ",
      "product_quantity": "500 cards",
      "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.",
      "recall_initiation_date": "20210406",
      "center_classification_date": "20210514",
      "report_date": "20210526",
      "code_info": "all lots"
    }
  ]
}